Zelira Therapeutics Ltd has released a press release.
Ilera Therapeutics Merger Completed and Board Changes
Filed with ASX ·
6ix hasn’t read this filing yet.
Zelira Therapeutics Ltd. on 6ix
Earlier from Zelira Therapeutics
- Agreement with Health House to Distribute Zelda Products
- Formulations to be supplied as part of CARE NSW trial
- Zeldas Phase II Insomnia Clinical Trial Fully Enrolled
- September 2019 Quarterly Report
- Zelda to merge with US-based Ilera Therapeutics
Later from Zelira Therapeutics
- Zelira Therapeutics expands HOPE distribution in the U.S.A
- Zelira to Collaborate with the Parkinsons Foundation
- December 2019 Quarterly Report
- Zelira Successfully Completes Capital Raising of $4.6M
- Zelira Meets Primary Endpoints for Insomnia Trial
Follow Zelira Therapeutics into a list and get an email when it puts out news.
Follow Zelira Therapeutics